Vivesto AB (VIVE.ST)

Sweden · Healthcare · SEK

Key financials

ROE: -24.09%; 2025 (actual)
ROA: -21.17%; 2025 (actual)
Gross Margin: -
Net Margin: -
Total Assets: SEK 149,039.00K; 2025 (actual)
Net Income: -SEK 34,082.00K; 2025 (actual)
Valuation: SEK 130,088.59K; 2025 (actual)
Stock Price: SEK 11.75; 2025 (actual)

Historical & projected performance

Reported figures and Equlion model projections for the next 5 years.

Metric	2025 (actual)	2026	2027	2028	2029	2030
ROE	-24.09%	-31.74%	-45.96%	-86.06%	-617.55%	119.33%
ROA	-21.17%	-23.06%	-22.99%	-23.19%	-23.19%	-23.19%
Total Assets	SEK 149,039.00K	SEK 147,013.00K	SEK 147,013.00K	SEK 147,013.00K	SEK 147,013.00K	SEK 147,013.00K
Sector average	SEK 2,857,190.78K	SEK 2,900,240.60K	SEK 3,045,009.79K	SEK 3,280,286.42K	SEK 3,536,407.14K	SEK 3,762,908.71K
Net Income	-SEK 34,082.00K	-SEK 34,127.84K	-SEK 33,801.03K

Amounts in SEK (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.

Want the full financial forecast report for Vivesto AB? It covers the balance sheet, income statement and Equlion model projections.

Valuation	SEK 130,088.59K	SEK 130,263.54K	SEK 129,016.15K	SEK 130,101.11K	SEK 130,105.65K	SEK 130,117.61K
Sector average	SEK 3,960,502.41K	SEK 5,151,301.60K	SEK 5,189,236.02K	SEK 5,317,343.69K	SEK 5,514,329.75K	SEK 5,636,782.17K

Stock Price	SEK 11.75	SEK 11.77	SEK 11.65	SEK 11.75	SEK 11.75	SEK 11.75
Sector average	SEK 57.22	SEK 48.04	SEK 48.69	SEK 50.45	SEK 52.13	SEK 53.41